Long-term Safety and Efficacy of Efgartigimod in Patients With Generalised Myasthenia Gravis

被引:0
|
作者
Meisel, A. [1 ,2 ]
Bril, V. [3 ,4 ]
Vu, T. [5 ]
Karam, C. [6 ]
Peric, S. [7 ]
De Bleecker, J. [8 ]
Murai, H. [9 ]
Beydoun, S. [10 ]
Pasnoor, M. [11 ]
Guglietta, A. [12 ]
Ulrichts, P. [12 ]
T'joen, C. [12 ]
Utsugisawa, K. [13 ]
Verschuuren, J. [14 ]
Mantegazza, R. [15 ]
Howard, J. [16 ]
机构
[1] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[2] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany
[3] Univ Hlth Network, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Univ S Florida, Dept Neurol, Morsani Coll Med, Tampa, FL USA
[6] Univ Penn, Penn Neurosci Ctr, Philadelphia, PA USA
[7] Univ Belgrade, Univ Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia
[8] Ghent Univ Hosp, Ghent, Belgium
[9] Int Univ Hlth & Welf, Sch Med, Dept Neurol, Tokyo, Japan
[10] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[11] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[12] Argenx, Ghent, Belgium
[13] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Japan
[14] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands
[15] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy
[16] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27515 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OPR-021
引用
收藏
页码:62 / 62
页数:1
相关论文
共 50 条
  • [21] Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients
    Wang, Pan
    Zhang, Bo
    Yin, Jian
    Xi, Jianying
    Tan, Ying
    Gao, Feng
    Zeng, Fan
    Chang, Ting
    Zhou, Hao
    Liang, Hui
    Zhao, Zhongyan
    Yang, Huan
    Zhao, Chongbo
    Huang, Shixiong
    [J]. FRONTIERS IN NEUROLOGY, 2024, 15
  • [22] Long-term outcome in patients with myasthenia gravis
    Bozovic, I.
    Ilic-Zivojinovic, J.
    Peric, S.
    Palibrk, A.
    Ivanovic, V.
    Rakocevic-Stojanovic, V.
    Lavrnic, D.
    Basta, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 501 - 501
  • [23] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Howard, James
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan
    Mantegazza, Renato
    [J]. NEUROLOGY, 2023, 100 (17)
  • [24] Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod PH20 in Patients with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC plus Study
    Ritt, Elissa
    Howard, James F., Jr.
    Li, George
    Vu, Tuan
    Korobko, Denis
    Smilowski, Marek
    Liu, Li
    Steeland, Sophie
    Noukens, Jan
    Van Hoorick, Benjamin
    Podhorna, Jana
    Li, Yuebing
    Utsugisawa, Kimiaki
    Sacca, Francesco
    Wiendl, Heinz
    De Bleecker, Jan L.
    Mantegazza, Renato
    [J]. ANNALS OF NEUROLOGY, 2023, 94 : S244 - S245
  • [25] THE EFFECT OF OBESITY IN EFFICACY AND SAFETY IN THE ADAPT TRIAL OF EFGARTIGIMOD FOR GENERALIZED MYASTHENIA GRAVIS
    Pulley, Michael
    Pasnoor, Mamatha
    Gelinas, Deborah
    Brauer, Edward
    Kerstens, Rene
    Beydoun, Said
    Howard, James
    [J]. MUSCLE & NERVE, 2022, 66 : S105 - S105
  • [26] Long-term treatment of generalised myasthenia gravis with FK506 (tacrolimus)
    Konishi, T
    Yoshiyama, Y
    Takamori, M
    Saida, T
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (03): : 448 - 450
  • [27] Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study
    Howard, James
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Peric, Stojan
    Murai, Hiroyuki
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    [J]. NEUROLOGY, 2021, 96 (15)
  • [28] Assessing the extent of symptom control provided by ravulizumab or efgartigimod in generalised myasthenia gravis
    Kielhorn, Adrian
    Werneburg, Brian
    Hagenacker, Tim
    Meuth, Sven
    Scheiner, Christopher
    Masuda, Masayuki
    Powell, Lauren
    Jayasinghe, Pramoda
    Johnston, Karissa
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [29] Long-term follow up of thymus in patients with myasthenia gravis
    Sugawara, Masashiro
    Wada, Chizu
    Okawa, Satoshi
    Kobayashi, Michio
    Abe, Erika
    Obara, Koji
    Kamada, Sachiko
    Ohnishi, Hirohide
    Toyoshima, Itaru
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2010, 221 (1-2) : 121 - 124
  • [30] Long-term immunologic effects of thymectomy in patients with myasthenia gravis
    Gerli, R
    Paganelli, R
    Cossarizza, A
    Muscat, C
    Piccolo, G
    Barbieri, D
    Mariotti, S
    Monti, D
    Bistoni, O
    Raiola, E
    Venanzi, FM
    Bertotto, A
    Franceschi, C
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (05) : 865 - 872